Extended Staphylococcus aureus persistence in cystic fibrosis is associated with bacterial adaptation

International Journal of Medical Microbiology

Volumn 303, Issue 8, 2013, Pages 685-692

  Hirschhausen, Nina ^a   Block, Desiree ^a   Bianconi, Irene ^c   Bragonzi, Alessandra ^c   Birtel, Johannes ^a,d   Lee, Jean C ^d   Dübbers, Angelika ^a   Küster, Peter ^e   Kahl, Janina ^a   Peters, Georg ^a,b   Kahl, Barbara C ^a,b  

^a UNIVERSITY HOSPITAL MÜNSTER   (Germany)

^b UNIVERSITY OF MÜNSTER   (Germany)

^c SAN RAFFAELE HOSPITAL   (Italy)

^d BRIGHAM AND WOMEN S HOSPITAL   (United States)

^e Clemenshospital Münster ^*  (Germany)

Author keywords

Adaptation; Airway infection; Cystic fibrosis; Persistence; Staphylococcus aureus

Indexed keywords

ADAPTATION; ADULT; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIAL CELL; BACTERIAL COLONIZATION; BACTERIAL LOAD; BACTERIAL VIRULENCE; BACTERIUM ISOLATE; BRONCHUS RUPTURE; CELL INFILTRATION; CYSTIC FIBROSIS; CYTOTOXICITY; DISEASE SEVERITY; GENOTYPE; HEMOLYSIS; HISTOPATHOLOGY; HUMAN; IMMUNOFLUORESCENCE; LUNG PARENCHYMA; MAJOR CLINICAL STUDY; MALE; MOLECULAR TYPING; MOUSE; MULTILOCUS SEQUENCE TYPING; NONHUMAN; PHENOTYPE; PNEUMONIA; STAPHYLOCOCCUS AUREUS;

ADAPTATION; AIRWAY INFECTION; CYSTIC FIBROSIS; PERSISTENCE; STAPHYLOCOCCUS AUREUS;

ADAPTATION, BIOLOGICAL; ADAPTATION, PHYSIOLOGICAL; ADOLESCENT; ADULT; ANIMALS; BRONCHI; CARRIER STATE; CHILD; CYSTIC FIBROSIS; DISEASE MODELS, ANIMAL; FEMALE; GENOTYPE; HUMANS; LONGITUDINAL STUDIES; LUNG; MALE; MICE; MICE, INBRED C57BL; MOLECULAR TYPING; PNEUMONIA, STAPHYLOCOCCAL; RETROSPECTIVE STUDIES; STAPHYLOCOCCUS AUREUS; VIRULENCE; YOUNG ADULT;

EID: 84887606624     PISSN: 14384221     EISSN: 16180607     Source Type: Journal    
DOI: 10.1016/j.ijmm.2013.09.012     Document Type: Article

References (33)

1. Bragonzi A., Paroni M., Nonis A., Cramer N., Montanari S., Rejman J., Di S.C., Doring G., Tummler B. Pseudomonas aeruginosa microevolution during cystic fibrosis lung infection establishes clones with adapted virulence. Am. J. Respir. Crit. Care Med. 2009, 180:138-145.
2. Cohen T.S., Prince A. Cystic fibrosis: a mucosal immunodeficiency syndrome. Nat. Med. 2012, 18:509-519.
3. Cystic Fibrosis Foundation, 2011. Cystic Fibrosis Foundation Patient Registry - 2010 Annual Data Report. Bethesda, MD.
4. Donlan R.M., Costerton J.W. Biofilms: survival mechanisms of clinically relevant microorganisms. Clin. Microbiol. Rev. 2002, 15:167-193.
5. Enright M.C., Day N.P., Davies C.E., Peacock S.J., Spratt B.G. Multilocus sequence typing for characterization of methicillin-resistant and methicillin-susceptible clones of Staphylococcus aureus. J. Clin. Microbiol. 2000, 38:1008-1015.
6. Garofalo A., Giai C., Lattar S., Gardella N., Mollerach M., Kahl B.C., Becker K., Prince A.S., Sordelli D.O., Gomez M.I. The length of the Staphylococcus aureus protein A polymorphic region regulates inflammation: impact on acute and chronic infection. J. Infect. Dis. 2012, 206:81-90.
7. Garzoni C., Kelley W.L. Staphylococcus aureus: new evidence for intracellular persistence. Trends Microbiol. 2009, 17:59-65.
8. Goerke C., Esser S., Kümmel M., Wolz C. Staphylococcus aureus strain designation by agr and cap polymorphism typing and delineation of agr diversification by sequence analysis. Int. J. Med. Microbiol. 2005, 295:67-75.
9. Goerke C., Gressinger M., Endler K., Breitkopf C., Wardecki K., Stern M., Wolz C., Kahl B.C. High phenotypic diversity in infecting but not in colonizing Staphylococcus aureus populations. Environ. Microbiol. 2007, 9:3134-3142.
10. Goerke C., Wolz C. Regulatory and genomic plasticity of Staphylococcus aureus during persistent colonization and infection. Int. J. Med. Microbiol. 2004, 294:195-202.
11. Goerke C., Wolz C. Adaptation of Staphylococcus aureus to the cystic fibrosis lung. Int. J. Med. Microbiol. 2010, 300:520-525.
12. Harmsen D., Claus H., Witte W., Rothgänger J., Turnwald D., Vogel U. Typing of methicillin-resistant Staphylococcus aureus in the University hospital setting using a novel software for spa repeat determination and database management. J. Clin. Microbiol. 2003, 41:5442-5448.
13. 2 inhibition in vitro and in vivo. J. Infect. Dis. 1997, 176:431-438.
14. Hogardt M., Heesemann J. Microevolution of Pseudomonas aeruginosa to a chronic pathogen of the cystic fibrosis lung. Curr. Top. Microbiol. Immunol. 2013, 358:91-118.
15. Kahl B., Herrmann M., Everding A.S., Koch H.G., Becker K., Harms E., Proctor R.A., Peters G. Persistent infection with small colony variant strains of Staphylococcus aureus in patients with cystic fibrosis. J. Infect. Dis. 1998, 177:1023-1029.
16. Kahl B.C. Impact of Staphylococcus aureus on the pathogenesis of chronic cystic fibrosis lung disease. Int. J. Med. Microbiol. 2010, 300:514-519.
17. Kahl B.C., Duebbers A., Lubritz G., Haeberle J., Koch H.G., Ritzerfeld B., Reilly M., Harms E., Proctor R.A., Herrmann M., Peters G. Population dynamics of persistent Staphylococcus aureus isolated from the airways of cystic fibrosis patients during a 6-year prospective study. J. Clin. Microbiol. 2003, 41:4424-4427.
18. Kahl B.C., Mellmann A., Deiwick S., Peters G., Harmsen D. Variation of the polymorphic region X of the protein A gene during persistent airway infection of cystic fibrosis patients reflects two independent mechanisms of genetic change in Staphylococcus aureus. J. Clin. Microbiol. 2005, 43:502-505.
19. Kriegeskorte A., König S., Sander G., Pirkl A., Mahabir E., Proctor R.A., von E.C., Peters G., Becker K. Small colony variants of Staphylococcus aureus reveal distinct protein profiles. Proteomics 2011, 11:2476-2490.
20. Lowy F.D. Staphylococcus aureus infections. N. Engl. J. Med. 1998, 339:520-532.
21. Martin F.J., Gomez M.I., Wetzel D.M., Memmi G., O'Seaghdha M., Soong G., Schindler C., Prince A. Staphylococcus aureus activates type I IFN signaling in mice and humans through the Xr repeated sequences of protein A. J. Clin. Invest. 2009, 119:1931-1939.
22. McKenney D., Pouliot K.L., Wang Y., Murthy V., Ulrich M., Döring G., Lee J.C., Goldmann D.A., Pier G.B. Broadly protective vaccine for Staphylococcus aureus based on an in vivo-expressed antigen. Science 1999, 284:1523-1527.
23. Mowat E., Paterson S., Fothergill J.L., Wright E.A., Ledson M.J., Walshaw M.J., Brockhurst M.A., Winstanley C. Pseudomonas aeruginosa population diversity and turnover in cystic fibrosis chronic infections. Am. J. Respir. Crit. Care Med. 2011, 183:1674-1679.
24. O'Riordan K., Lee J.C. Staphylococcus aureus capsular polysaccharides. Clin. Microbiol. Rev. 2004, 17:218-234.
25. O'Sullivan B.P., Freedman S.D. Cystic fibrosis. Lancet 2009, 373:1891-1904.
26. Proctor R.A., Eiff von C., Kahl B.C., Becker K., Mc Namara P.J., Herrmann M., Peters G. Small colony variants: a pathogenic form of bacteria that facilitates persistent and recurrent infections. Nat. Rev. Microbiol. 2006, 4:295-305.
27. Risley A.L., Loughman A., Cywes-Bentley C., Foster T.J., Lee J.C. Capsular polysaccharide masks clumping factor A-mediated adherence of Staphylococcus aureus to fibrinogen and platelets. J. Infect. Dis. 2007, 196:919-927.
28. Smith E.E., Buckley D.G., Wu Z., Saenphimmachak C., Hoffman L.R., D'Argenio D.A., Miller S.I., Ramsey B.W., Speert D.P., Moskowitz S.M., Burns J.L., Kaul R., Olson M.V. Genetic adaptation by Pseudomonas aeruginosa to the airways of cystic fibrosis patients. Proc. Natl. Acad. Sci. U. S. A. 2006, 103:8487-8492.
29. Stone A., Saiman L. Update on the epidemiology and management of Staphylococcus aureus, including methicillin-resistant Staphylococcus aureus, in patients with cystic fibrosis. Curr. Opin. Pulm. Med. 2007, 13:515-521.
30. Tuchscherr L., Medina E., Hussain M., Volker W., Heitmann V., Niemann S., Holzinger D., Roth J., Proctor R.A., Becker K., Peters G., Loffler B. Staphylococcus aureus phenotype switching: an effective bacterial strategy to escape host immune response and establish a chronic infection. EMBO Mol. Med. 2011, 3:129-141.
31. Tuchscherr L.P., Buzzola F.R., Alvarez L.P., Caccuri R.L., Lee J.C., Sordelli D.O. Capsule-negative Staphylococcus aureus induces chronic experimental mastitis in mice. Infect. Immun. 2005, 73:7932-7937.
32. Viviani L., Zolin A., Olesen H.V. European Cystic Fibrosis Foundation Patient Registry - Annual Data Report 2008-2009 2012.
33. Wertheim H.F., Melles D.C., Vos M.C., van L.W., van B.A., Verbrugh H.A., Nouwen J.L. The role of nasal carriage in Staphylococcus aureus infections. Lancet Infect. Dis. 2005, 5:751-762.